![(3S,5R,8S,9S,10R,13R,14S,17R)-3,5-DIHYDROXY-10,13-DIMETHYL-17-((R)-6-METHYLHEPTAN-2-YL)TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-6(10H)-ONE structure, CAS 13027-33-3](/structures/100000/96923_1_13027_33_3.png)
CAS Number13027-33-3
SynonymsCHOLESTANE-6-OXO-3,5-DIOL; (3β,5α)-3,5-Dihydroxycholestan-6-one; CHOLESTANE-6-OXO-3BETA,5ALPHA-DIOL; 5ALPHA-HYDROXY-6-KETO CHOLESTEROL; YS-64; yakkasterone; 3β,5α-Dihydroxycholestan-6-one
Molecular FormulaC27H46O3
Molecular Weight418.65
Purity>99 (TLC)%
Density1.1±0.1 g/cm3
Boiling Point528.9±45.0 °C at 760 mmHg
Appearancepowder
EINECS0
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 13027-33-3 |
| Catalog No. | 2A-0096923 |
| Chinese Name | 3,5二羟基胆甾-6-酮 |
| Synonyms | CHOLESTANE-6-OXO-3,5-DIOL; (3β,5α)-3,5-Dihydroxycholestan-6-one; CHOLESTANE-6-OXO-3BETA,5ALPHA-DIOL; 5ALPHA-HYDROXY-6-KETO CHOLESTEROL; YS-64; yakkasterone; 3β,5α-Dihydroxycholestan-6-one |
| Molecular Formula | C27H46O3 |
| Molecular Weight | 418.65 |
| Purity | >99 (TLC) |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 528.9±45.0 °C at 760 mmHg |
| Appearance | powder |
| Application | 5α-Hydroxy-6-ketocholesterol is the major metabolite of β-epoxide (5α,6β-epoxycholesterol) during direct exposure of intact cultured human bronchial epithelial cells (16-HBE) to ozone. 5α-Hydroxy-6-ke |
| EINECS | 0 |
| HTC | 0 |
| UN(IATA) | 0 |
| PubChem ID | 10253615 |
| MDL Number | MFCD00271438 |
| SMILES | O[C@]21[C@@]([C@@H]3[C@H]([C@H]4[C@@]([C@H](CC4)[C@@H](CCCC(C)C)C)(CC3)C)CC2=O)(CC[C@@H](C1)O)C |
| InChI | 1S/C27H46O3/c1-17(2)7-6-8-18(3)21-9-10-22-20-15-24(29)27(30)16-19(28)11-14-26(27,5)23(20)12-13-25(21,22)4/h17-23,28,30H,6-16H2,1-5H3/t18-,19+,20+,21-,22+,23+,25-,26-,27+/m1/s1 |
| InChI Key | SJZZRXMQSAXCFD-ZCBMJONGSA-N |
| NACRES Code | NA.25 |
| UNSPSC | 12352211 |
| MSDS | msds/96923_1_13027_33_3.pdf |
| Transport Info | Product name: 5α-Hydroxy-6-ketocholesterol |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA